INTERVIEW
maximizing shelf life and minimizing wastage during transit. PharmNXT Biotech is building a robust ecosystem where India is not a passive consumer of biotech innovation but an active producer, setting new global benchmarks in affordability, accessibility, and quality.
Your major product offerings and latest innovations to enhance biomanufacturing efficiency?
Biomanufacturing has shifted focus from just being efficient to staying ahead of the curve. The industry is advancing rapidly, and the true driving forces are innovation, the ability to operate independently, and expanding operations to a larger scale.
First, our single-use consumables— including storage bags, mixer bags, powder bags, manifolds, assemblies, and liners— are produced in our globally certified Pune facility, eliminating costly imports while ensuring international-grade quality. Second, our hardware vertical delivers cutting-edge bioprocessing equipment, from stainless-steel mixers and storage vessels to filtration skids, chromatography systems, inline buffer preparation systems, and viral filtration units— all manufactured in India to drive down costs and lead times. Third, our global partnerships
are bringing high-quality chromatography resins and precise freezing technologies to India, smoothly integrating them into end-toend production workflows. By producing locally and tapping into global expertise, we are making biomanufacturing faster, leaner, and more accessible. Our mission is clear: position India as a global leader in biopharmaceutical innovation while expanding access to life-saving therapies worldwide.
The company has made significant strides in producing Single-Use products and containment solutions. What inspired the shift to in-house manufacturing, and how does it give you a competitive edge in the global market?
Our shift to in-house manufacturing of single-use products and containment solutions was driven by firsthand experience in the biopharma industry. Having worked with global biopharma leaders, our team has witnessed bottlenecks, cost pressures, and supply chain vulnerabilities stemming from India’ s growing sector. We built PharmNXT Biotech to solve these challenges, ensuring that India is not just a participant but a global leader in biomanufacturing innovation.
Our 20,000 sq. ft. Ekuse facility, fully
34
BioVoiceNews | April 2025